S. Eckhardt

584 total citations
44 papers, 397 citations indexed

About

S. Eckhardt is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, S. Eckhardt has authored 44 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in S. Eckhardt's work include Cancer therapeutics and mechanisms (4 papers), Amino Acid Enzymes and Metabolism (3 papers) and Glioma Diagnosis and Treatment (3 papers). S. Eckhardt is often cited by papers focused on Cancer therapeutics and mechanisms (4 papers), Amino Acid Enzymes and Metabolism (3 papers) and Glioma Diagnosis and Treatment (3 papers). S. Eckhardt collaborates with scholars based in Hungary, United Kingdom and United States. S. Eckhardt's co-authors include F Badellino, G.P. Murphy, S. Kerpel‐Fronius, Paul Johnson, Cheikhou Kane, MT Dattani, Peter J. Milla, László Institóris, A Aynsley‐Green and Ruth M. Shepherd and has published in prestigious journals such as The Lancet, Cancer and Annals of the New York Academy of Sciences.

In The Last Decade

S. Eckhardt

42 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Eckhardt Hungary 12 134 113 79 78 61 44 397
Chuichi Itoh Japan 14 93 0.7× 98 0.9× 40 0.5× 34 0.4× 86 1.4× 37 418
Yuzo Minami Japan 11 123 0.9× 81 0.7× 129 1.6× 60 0.8× 89 1.5× 35 373
C Gilbert United States 10 372 2.8× 85 0.8× 52 0.7× 46 0.6× 26 0.4× 12 687
Julie Bélanger Canada 9 174 1.3× 110 1.0× 63 0.8× 22 0.3× 107 1.8× 9 381
JR Lillehaug Norway 6 205 1.5× 188 1.7× 32 0.4× 84 1.1× 31 0.5× 7 419
Y. Horn Israel 12 120 0.9× 117 1.0× 72 0.9× 52 0.7× 102 1.7× 57 431
Yoshitaka Seki Japan 13 175 1.3× 107 0.9× 110 1.4× 22 0.3× 66 1.1× 38 424
Masashi Kitahara Japan 12 52 0.4× 122 1.1× 60 0.8× 20 0.3× 57 0.9× 25 435
M Usami Japan 10 66 0.5× 95 0.8× 272 3.4× 71 0.9× 56 0.9× 37 397
Paolo Marolla Italy 10 170 1.3× 77 0.7× 24 0.3× 17 0.2× 38 0.6× 16 322

Countries citing papers authored by S. Eckhardt

Since Specialization
Citations

This map shows the geographic impact of S. Eckhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Eckhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Eckhardt more than expected).

Fields of papers citing papers by S. Eckhardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Eckhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Eckhardt. The network helps show where S. Eckhardt may publish in the future.

Co-authorship network of co-authors of S. Eckhardt

This figure shows the co-authorship network connecting the top 25 collaborators of S. Eckhardt. A scholar is included among the top collaborators of S. Eckhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Eckhardt. S. Eckhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eckhardt, S., Clare Richardson, Klane K. White, et al.. (2024). Rates of tracheostomy in patients with complex skeletal dysplasia: A 32-year institutional experience. International Journal of Pediatric Otorhinolaryngology. 186. 112129–112129.
2.
Knoll, J., Kornélia Baghy, S. Eckhardt, et al.. (2017). A longevity study with enhancer substances (selegiline, BPAP) detected an unknown tumor-manifestation-suppressing regulation in rat brain. Life Sciences. 182. 57–64. 7 indexed citations
3.
Horti, J, et al.. (2008). Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative, for the treatment of patients with non-small cell lung cancer. Cancer Chemotherapy and Pharmacology. 62(1). 173–180. 18 indexed citations
4.
Eckhardt, S., F Badellino, & G.P. Murphy. (1994). UICC meeting on breast-cancer screening in pre-menopausal women in developed countries. Cancer. 73(3). 745–749. 13 indexed citations
5.
Jassem, Jacek, S. Kerpel‐Fronius, Jaap Verweij, et al.. (1993). Combination of daily 4-h infusion of 5-fluorouracil and cisplatin in the treatment of advanced head and neck squamous-cell carcinoma: A South-East European Oncology Group study. Cancer Chemotherapy and Pharmacology. 31(6). 489–494. 10 indexed citations
6.
Vincze, B., S. Kerpel‐Fronius, S. Eckhardt, et al.. (1990). Hormonal effects of toremifene in breast cancer patients. Journal of Steroid Biochemistry. 36(3). 243–247. 7 indexed citations
7.
Eckhardt, S., Krsto Kolarić, J Jassem, et al.. (1990). Phase II study of 4'-epi-doxorubicin in patients with untreated, extensive small cell lung cancer. South-East European Oncology Group (SEEOG).. PubMed. 7(1). 19–23. 7 indexed citations
8.
Vincze, B., et al.. (1988). Influence of Antiestrogen Drugs on the Sex Hormone and Sex Hormone‐Binding Globulin Levels in Breast Cancer Patients. Annals of the New York Academy of Sciences. 538(1). 265–279. 6 indexed citations
9.
Sinkovics, István, et al.. (1988). Ifosfamide chemotherapy of metastatic renal cell cancer.. PubMed. 4(2). 95–6. 4 indexed citations
10.
Kerpel‐Fronius, S., Kiterie M. E. Faller, Zdeněk Mechl, et al.. (1987). Phase I–II Trial of Aclacinomycin A Given in a Four-Consecutive-Day Schedule to Patients with Solid Tumours. Oncology. 44(3). 159–163. 2 indexed citations
11.
Lapis, K. & S. Eckhardt. (1987). Endocrine Aspects of Malignancies. Medical Entomology and Zoology. 3 indexed citations
12.
Issell, Brian F., et al.. (1982). Dibromodulcitol plus bleomycin compared with bleomycin alone in head and neck cancer. Cancer Chemotherapy and Pharmacology. 8(2). 171–3. 3 indexed citations
13.
Mihich, Enrico & S. Eckhardt. (1980). Design of cancer chemotherapy: experimental and clinical approaches.. PubMed. 28. 1–185. 2 indexed citations
14.
Fodor, János, et al.. (1979). Basal Cell Carcinoma Treated with MTDQ and Irradiation. PubMed. 18(2). 97–102. 1 indexed citations
15.
Prajda, N, et al.. (1979). Biochemical behavior of MC‐29 virus‐induced transplantable chicken hepatoma. Journal of Toxicology and Environmental Health. 5(2-3). 503–508. 8 indexed citations
16.
Eckhardt, S.. (1979). Chemotherapy of primary liver cancer. Journal of Toxicology and Environmental Health. 5(2-3). 395–400. 3 indexed citations
17.
Eckhardt, S., et al.. (1977). Uptake of labeled dianhydrogalactitol into human gliomas and nervous tissue.. PubMed. 61(5). 841–7. 13 indexed citations
18.
Könyves, I., et al.. (1974). Estracyt in hormone-resistant prostatic carcinoma. International Urology and Nephrology. 6(2). 101–110. 6 indexed citations
19.
Eckhardt, S., et al.. (1973). Combined postoperative treatment of malignant supratentorial gliomas with vincristine sulphate and radiotherapy. Acta Neurochirurgica. 29(3-4). 203–211.
20.
Eckhardt, S., et al.. (1973). Recent data on the mechanism of action of oestrogens in the treatment of prostatic tumour patients. International Urology and Nephrology. 5(3). 311–323. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chuichi Itoh Breakdown of academic impact, for papers by Yuzo Minami Breakdown of academic impact, for papers by C Gilbert Breakdown of academic impact, for papers by Julie Bélanger Breakdown of academic impact, for papers by JR Lillehaug Breakdown of academic impact, for papers by Y. Horn Breakdown of academic impact, for papers by Yoshitaka Seki Breakdown of academic impact, for papers by Masashi Kitahara Breakdown of academic impact, for papers by M Usami Breakdown of academic impact, for papers by Paolo Marolla
Rankless by CCL
2026